Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Therapeutics

Leukemia Cells Are Killed in Culture by Immune Cells Grown from the Same Patient

Immune system natural killer cells were isolated from leukemia patients, expanded in culture, and then shown in an in vitro system to attack and destroy cancer cells from the original cell donors.  More...
01 Sep 2014
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice.  More...
25 Aug 2014

Biotechnology Merger to Spur Development of a Gene Therapy Approach for Treatment of Congestive Heart Failure

Rapid improvement in the treatment of congestive heart failure is expected following the acquisition of InoCard, a German early-stage biotechnology company by uniQure, a Dutch leader in the field of gene therapy.  More...
24 Aug 2014

Gene Therapy Reactivates Cell Death Pathways in Cervical Cancer Cells

A team of molecular virologists has presented evidence demonstrating the possibility of developing anticancer therapies based on viral vectors that transfect carcinoma cells with RNA-protein complexes capable of reactivating genes in the cancer cells that cause cell cycle arrest and eventual cell death.  More...
18 Aug 2014

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose metabolism.  More...
31 Jul 2014

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research.   More...
30 Jul 2014
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.  More...
30 Jul 2014


BioResearch Therapeutics channel deals with all aspects of therapies beyond the five-year horizon.
 
Copyright © 2000-2014 Globetech Media. All rights reserved.